The Manufacturers Life Insurance Company Takes $4.56 Million Position in Palomar Holdings, Inc. $PLMR

Posted by Geri Gentry on Sep 1st, 2026

The Manufacturers Life Insurance Company purchased a new position in Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 36,073 shares of the company’s stock, valued at approximately $4,559,000. The Manufacturers Life Insurance Company owned 0.14% of Palomar as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Janus Henderson Group PLC raised its holdings in shares of Palomar by 17.4% in the 1st quarter. Janus Henderson Group PLC now owns 933,993 shares of the company’s stock valued at $111,664,000 after acquiring an additional 138,368 shares in the last quarter. HighTower Advisors LLC grew its holdings in shares of Palomar by 652.7% during the fourth quarter. HighTower Advisors LLC now owns 17,613 shares of the company’s stock worth $2,374,000 after purchasing an additional 15,273 shares in the last quarter. Stephens Investment Management Group LLC grew its holdings in shares of Palomar by 19.8% during the fourth quarter. Stephens Investment Management Group LLC now owns 694,317 shares of the company’s stock worth $93,566,000 after purchasing an additional 114,859 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Palomar by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 2,698,278 shares of the company’s stock worth $363,620,000 after purchasing an additional 67,038 shares during the last quarter. Finally, Deutsche Bank AG bought a new position in shares of Palomar in the second quarter worth approximately $6,131,000. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Palomar Stock Up 0.7%

Shares of PLMR opened at $132.57 on Tuesday. The firm has a market cap of $3.49 billion, a P/E ratio of 17.82 and a beta of 0.40. The stock has a 50 day simple moving average of $133.03 and a two-hundred day simple moving average of $124.15. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.50 and a quick ratio of 0.50. Palomar Holdings, Inc. has a 1 year low of $100.81 and a 1 year high of $147.62.

Palomar (NASDAQ:PLMR – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $2.36 EPS for the quarter, topping the consensus estimate of $2.19 by $0.17. The firm had revenue of $314.42 million for the quarter, compared to the consensus estimate of $621.52 million. Palomar had a net margin of 18.61% and a return on equity of 23.28%. During the same period last year, the firm posted $1.76 earnings per share. On average, analysts forecast that Palomar Holdings, Inc. will post 9.21 earnings per share for the current fiscal year.

Palomar Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 2nd. Investors of record on Wednesday, August 19th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Wednesday, August 19th. Palomar’s dividend payout ratio (DPR) is presently 24.19%.

Insiders Place Their Bets

In other news, COO Rodolphe Herve sold 1,207 shares of the firm’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $135.35, for a total transaction of $163,367.45. Following the transaction, the chief operating officer directly owned 3,548 shares of the company’s stock, valued at approximately $480,221.80. This trade represents a 25.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Jonathan Knutzen sold 296 shares of Palomar stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $127.75, for a total value of $37,814.00. Following the completion of the transaction, the insider owned 28,250 shares in the company, valued at approximately $3,608,937.50. This represents a 1.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 23,665 shares of company stock valued at $3,138,093 over the last three months. 3.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

PLMR has been the subject of several research analyst reports. Zacks Research lowered shares of Palomar from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 15th. Weiss Ratings raised shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. Piper Sandler raised their price objective on shares of Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Evercore set a $152.00 price objective on shares of Palomar in a report on Friday, July 10th. Finally, JPMorgan Chase & Co. upped their target price on shares of Palomar from $150.00 to $167.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $162.75.

Read Our Latest Research Report on Palomar

Palomar Company Profile

(Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.